Evidence-Based Policy Making: Assessment of the American Heart Association’s Strategic Policy Portfolio
Darwin R. Labarthe(UK Health Forum), Laurie P. Whitsel(American Heart Association), Leighton Ku(Milken Institute), Elliott M. Antman(Brigham and Women's Hospital), Donna K. Arnett(University of Alabama at Birmingham), Mark J. Alberts(Nanotherapeutics (United States)), Laura L. Hayman, Mark A. Creager(Dartmouth–Hitchcock Medical Center), James F. Sallis(University of California San Diego), Penny M. Kris‐Etherton(Pennsylvania State University), Suhui Li, Linda Van Horn(Unknown), Stephen R. Daniels(Children's Hospital Colorado), Larry B. Goldstein(University of Kentucky), Gregg C. Fonarow(UCLA Medical Center), Ralph L. Sacco(University of Miami), Jennifer G. Robinson(University of Iowa), Aruni Bhatnagar(American Heart Association), Paula M. Lantz(The Centre for Health (New Zealand)), Amit Khera(Southwestern Medical Center)
Cited by 45
Related Papers
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2007|6.7k
Edoxaban versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2013|5.2k
Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction
|Circulation|2010|4.8k
Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery
|Journal of the American College of Cardiology|2002|4.6k